Asante Solutions (NASDAQ: PUMP) and NeuroMetrix (NASDAQ:NURO) are both small-cap healthcare companies, but which is the superior investment? We will compare the two companies based on the strength of their profitability, earnings, risk, institutional ownership, valuation, analyst recommendations and dividends.
This table compares Asante Solutions and NeuroMetrix’s net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
Earnings and Valuation
This table compares Asante Solutions and NeuroMetrix’s revenue, earnings per share and valuation.
|Gross Revenue||Price/Sales Ratio||EBITDA||Earnings Per Share||Price/Earnings Ratio|
|Asante Solutions||$666.25 million||1.44||$51.36 million||N/A||N/A|
|NeuroMetrix||$15.72 million||0.27||-$13.27 million||($20.01)||-0.10|
Asante Solutions has higher revenue and earnings than NeuroMetrix.
Institutional and Insider Ownership
6.5% of NeuroMetrix shares are held by institutional investors. 4.4% of NeuroMetrix shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.
This is a breakdown of recent recommendations and price targets for Asante Solutions and NeuroMetrix, as reported by MarketBeat.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
Asante Solutions presently has a consensus target price of $18.70, suggesting a potential upside of 61.35%. NeuroMetrix has a consensus target price of $26.00, suggesting a potential upside of 1,200.00%. Given NeuroMetrix’s stronger consensus rating and higher probable upside, analysts plainly believe NeuroMetrix is more favorable than Asante Solutions.
About Asante Solutions
Asante Solutions, Inc. is a medical device company. The Company is a manufacturer of Asante Snap Insulin Pump System (Snap system), which is a pump featuring a modular design with pre-filled insulin cartridges and disposable pump bodies, utilized in combination with a controller. The Snap system comprises four components: the Snap system controller, a disposable pump body, disposable pre-filled insulin cartridges and disposable infusion sets. The Snap system also incorporates a technology that allows for auto-priming, whereby, without user intervention, the infusion tubing is automatically filled with insulin every time a new cartridge is inserted. The disposable pump body, which contains a fresh battery, is designed to be used for a week. The Company markets the Snap system through distributors of medical equipment and supplies to individuals with diabetes.
NeuroMetrix, Inc. is a healthcare company combining bioelectrical and digital medicine to address chronic health conditions, including chronic pain, sleep disorders and diabetes. The Company is engaged in the sale of medical equipment, and consumables and accessories. It has two principal product lines: Wearable neuro-stimulation therapeutic devices and Point-of-care neuropathy diagnostic tests. Its products include ADVANCE NCS/EMG System (the ADVANCE System), Quell, SENSUS and DPNCheck. Quell is a wearable device for relief of chronic intractable pain, such as nerve pain due to diabetes and lower back problems. The SENSUS pain therapy device, the technological predecessor to Quell, is a prescription neuro-stimulation device based on transcutaneous electrical nerve stimulation (TENS) for relief of chronic, intractable pain. DPNCheck is a quantitative nerve conduction test. ADVANCE System is a platform for the performance of traditional nerve conduction studies.
Receive News & Ratings for Asante Solutions Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Asante Solutions Inc and related companies with our FREE daily email newsletter.